- Corporate Officers - W
- Wyzga Michael S
Insider Trading History of Wyzga Michael S
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Wyzga Michael S since 2007.
This trader's CIK number is 1201256.
At the time of last reporting, Wyzga Michael S was the Director of X4 Pharmaceuticals, Inc. (stock ticker symbol XFOR).
Also see all insider trading activities at X4 Pharmaceuticals, Inc.
Note that in the past
WYZGA MICHAEL S also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Exact Sciences Corp (EXAS) by Wyzga Michael S
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | EXAS | 0 | $0 | 19,021 | $2,474,822 | 10,108 | $272,713 |
| 2019 | EXAS | 0 | $0 | 5,500 | $637,650 | 2,500 | $67,450 |
| 2018 | EXAS | 0 | $0 | 9,870 | $566,176 | 0 | $0 |
Yearly summary of insider trading at Genzyme Corp (GENZ) by Wyzga Michael S
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | GENZ | 0 | $0 | 0 | $0 | 29,250 | $0 |
| 2010 | GENZ | 0 | $0 | 5,068 | $231,252 | 15,000 | $0 |
| 2008 | GENZ | 0 | $0 | 29,390 | $2,321,810 | 29,390 | $1,043,727 |
| 2007 | GENZ | 0 | $0 | 5,140 | $384,934 | 5,140 | $222,870 |
Yearly summary of insider trading at Akebia Therapeutics, Inc. (AKBA) by Wyzga Michael S
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | AKBA | 1,500 | $25,500 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Logicbio Therapeutics, Inc. (LOGC) by Wyzga Michael S
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | LOGC | 0 | $0 | 0 | $0 | 3,141 | $0 |
Yearly summary of insider trading at X4 Pharmaceuticals, Inc (XFOR) by Wyzga Michael S
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | XFOR | 25,000 | $29,875 | 0 | $0 | 0 | $0 |
Insider trading activities at 5 companies by Wyzga Michael S:
1. Exact Sciences Corp (EXAS)
2. Genzyme Corp (GENZ)
3. Akebia Therapeutics, Inc. (AKBA)
4. Logicbio Therapeutics, Inc. (LOGC)
5. X4 Pharmaceuticals, Inc (XFOR)
Table 1. Insider trading of Exact Sciences Corp (EXAS) by Wyzga Michael S
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-02-26 | EXAS | Option Ex | 10,108 | 26.98 | 272,713 |
| 2021-02-26 | EXAS | Sale | 19,021 | 130.11 | 2,474,822 |
| 2019-07-31 | EXAS | Option Ex | 2,500 | 26.98 | 67,450 |
| 2019-07-31 | EXAS | Sale | 5,000 | 117.93 | 589,650 |
| 2019-02-28 | EXAS | Sale | 500 | 96.00 | 48,000 |
| 2018-08-28 | EXAS | Sale | 2,468 | 74.85 | 184,729 |
| 2018-05-10 | EXAS | Sale | 7,402 | 51.53 | 381,447 |
Table 2. Insider trading of Genzyme Corp (GENZ) by Wyzga Michael S
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-04-04 | GENZ | Option Ex | 29,250 | .00 | 0 |
| 2010-05-25 | GENZ | Sale | 5,068 | 45.63 | 231,252 |
| 2010-05-24 | GENZ | Option Ex | 15,000 | .00 | 0 |
| 2008-08-12 | GENZ | Option Ex | 29,390 | 35.51 | 1,043,727 |
| 2008-08-12 | GENZ | Sale | 29,390 | 79.00 | 2,321,810 |
| 2007-12-17 | GENZ | Option Ex | 5,140 | 43.36 | 222,870 |
| 2007-12-17 | GENZ | Sale | 5,140 | 74.89 | 384,934 |
Table 3. Insider trading of Akebia Therapeutics, Inc. (AKBA) by Wyzga Michael S
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-03-25 | AKBA | Buy | 1,500 | 17.00 | 25,500 |
Table 4. Insider trading of Logicbio Therapeutics, Inc. (LOGC) by Wyzga Michael S
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-01-01 | LOGC | Option Ex | 3,141 | .00 | 0 |
Table 5. Insider trading of X4 Pharmaceuticals, Inc (XFOR) by Wyzga Michael S
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-08-18 | XFOR | Buy | 25,000 | 1.20 | 29,875 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Wyzga Michael S
(Director of X4 Pharmaceuticals, Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.